Archives
CMA consider appeal in phenytoin competition case
The CMA is considering an appeal in the phenytoin competition case after a Tribunal found that the CMA ruling of market abuse is incorrect.
The phenytoin competition case is one of the most pivotal cases of our time in terms of the cost of drugs to the NHS. A number of investigations and findings have been made against pharmaceutical giants for overcharging the NHS, putting huge strains on public finances, and the CMA’s intervention is vital for the survival of our public health service.
The Tribunal decision in the phenytoin competition case is a setback that the CMA is now considering an appeal for.
Google competition breach yields massive fine
A Google competition breach has yielded a massive fine imposed by the European Commission over its behaviour surrounding Android phones.
The fine amounts to £3.9bn ($5bn) and is based on Google’s search-related revenue earned during the period the competition breach is said to have taken place.
The investigations into the Google competition breach stem back to 2015 and surround impositions of pre-installed browsers and search apps that it’s claimed has led to users not looking for alternatives, with Google paying huge sums to manufacturers to pre-install its own software.